94193-37-0

Basic information

• Product Name: Butanoyl chloride, 4-(3-formyl-4-nitrophenoxy)-
• CAS NO: 94193-37-0
• Molecular Formula: C11H10ClNO5
• Molecular Weight: 271.657
• Mol File: 94193-37-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Butanoyl chloride, 4-(3-formyl-4-nitrophenoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoyl chloride, 4-(3-formyl-4-nitrophenoxy)-(94193-37-0)
• EPA Substance Registry System: Butanoyl chloride, 4-(3-formyl-4-nitrophenoxy)-(94193-37-0)

Safety Data

• Hazardous Substances Data: 94193-37-0(Hazardous Substances Data)

Upstream product

• 94193-35-8 ethyl 4-((3-formyl-4-nitrophenyl)oxy)butyrate 
• 42454-06-8 2-nitro-5-hydroxybenzaldehyde 

Downstream Products

• 94193-39-2 N-Cyclohexyl-4-(3-formyl-4-nitro-phenoxy)-N-(2-hydroxy-ethyl)-butyramide 
• 105695-15-6 5-[4-(2,3-Dihydro-indol-1-yl)-4-oxo-butoxy]-2-nitro-benzaldehyde 
• 94193-47-2 5-[4-(3,4-Dihydro-2H-quinolin-1-yl)-4-oxo-butoxy]-2-nitro-benzaldehyde 
• 94193-48-3 5-[4-(3,4-Dihydro-1H-isoquinolin-2-yl)-4-oxo-butoxy]-2-nitro-benzaldehyde 
• 105695-11-2 N-Cyclopentyl-4-(3-formyl-4-nitro-phenoxy)-N-methyl-butyramide 
• 105695-13-4 N-Cyclooctyl-4-(3-formyl-4-nitro-phenoxy)-N-methyl-butyramide 
• 99694-61-8 {Cyclohexyl-[4-(3-formyl-4-nitro-phenoxy)-butyryl]-amino}-acetic acid methyl ester 
• 105695-12-3 N-Cycloheptyl-4-(3-formyl-4-nitro-phenoxy)-N-methyl-butyramide 
• 94193-41-6 N-Benzyl-4-(3-formyl-4-nitro-phenoxy)-N-methyl-butyramide 
• 105695-14-5 N-phenyl-N-methyl-4-(3-formyl-4-nitrophenyl)oxybutyramide 
• 105695-16-7 2-Nitro-5-((4aS,8aR)-4-octahydro-quinolin-1-yl-4-oxo-butoxy)-benzaldehyde 
• 105695-17-8 5-{4-[2-(2,2-Dicyclohexyl-ethyl)-piperidin-1-yl]-4-oxo-butoxy}-2-nitro-benzaldehyde 
• 99694-62-9 N-Carbamoylmethyl-N-cyclohexyl-4-(3-formyl-4-nitro-phenoxy)-butyramide 
• 105695-20-3 N-Cyclohexyl-4-(3-formyl-4-nitro-phenoxy)-N-(5-hydroxy-pentyl)-butyramide 

Relevant articles and documents

Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide

Evaluation of a series of lactam heterocyclic analogues of cilostamide as inhibitors of cyclic AMP phosphodiesterase derived from both human platelets and rat heart in comparison with their corresponding methoxy-substituted heterocycles has revealed that the N-cyclohexyl-N-methyl-4-oxybutyramide side chain of 2 is an important lipophilic and/or steric pharmacophore. Attachment of this side chain to the parent heterocycle of the potent cyclic AMP phosphodiesterase inhibitor anagrelide afforded the hybrid structure RS-82856, shown to be more potent than either of its progenitors as an inhibitor of cyclic AMP phosphodiesterase or of ADP-induced platelet aggregation. The available in vitro data suggest that 1 possesses potentially useful antithrombotic and cardiotonic properties.